Opening book details…
About this Medicine article
D09Circulating pro-angiogenic markers in patients receiving first-line FOLFIRI + Bevacizumab. The SENTRAL (Serum angiogenesis-cENTRAL) pre-planned analysis of the Italian Research Group for Digestive Tract Cancer (GISCAD) CENTRAL trial (ColorEctalvastiNTRiAlLdh) by Giampieri, R.; Scartozzi, M.; Daniele, B.; Ferrari, D.; Lonardi, S.; Zaniboni, A.; Cavanna, L.; Rosati, G.; Pella, N.; Zampino, M.G.; Sozzi, P.; Casula, L.; Rota, S.; Germano, D.; Puzzoni, M.; Loretelli, C.; Zagonel, V.; Labianca, R.; Frontini, L.; Cascinu, S. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Giampieri, R.; Scartozzi, M.; Daniele, B.; Ferrari, D.; Lonardi, S.; Zaniboni, A.; Cavanna, L.; Rosati, G.; Pella, N.; Zampino, M.G.; Sozzi, P.; Casula, L.; Rota, S.; Germano, D.; Puzzoni, M.; Loretelli, C.; Zagonel, V.; Labianca, R.; Frontini, L.; Cascinu, S.
- Publisher
- Oxford University Press; Elsevier BV (ISSN 0923-7534)
- Published
- 2016
- Field
- Medicine (Health Sciences)